approval
saveGABAPENTIN — FDA approval
community read0 votes
Sponsor: ACTAVIS ELIZABETH. Form: CAPSULE. Route: ORAL
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 8
- approvalGABAPENTIN — FDA approvalApr 2, 2026 · 187d ago
- approvalGABAPENTIN — FDA approvalMar 6, 2026 · 214d ago
- approvalGABAPENTIN — FDA approvalJan 29, 2026 · 250d ago
- approvalGABAPENTIN — FDA approvalDec 17, 2025 · 293d ago
- approvalGABAPENTIN — FDA approvalNov 24, 2025 · 316d ago
- approvalGABAPENTIN — FDA approvalSep 19, 2025 · 382d ago
- approvalGABAPENTIN — FDA approvalJul 21, 2025 · 442d ago
- approvalGABAPENTIN — FDA approvalJul 21, 2025 · 442d ago
same company · ±60 days · 6
- approvalOXYMORPHONE HYDROCHLORIDE: OXYMORPHONE HYDROCHLORIDE — FDA approvalJan 5, 2026
- approvalBUPRENORPHINE HYDROCHLORIDE: BUPRENORPHINE HYDROCHLORIDE — FDA approvalDec 31, 2025
- approvalMidol: OXYCODONE HYDROCHLORIDE AND IBUPROFEN (IBUPROFEN) — FDA approvalDec 23, 2025
- approvaltramadol hydrochloride ER: TRAMADOL HYDROCHLORIDE — FDA approvalDec 23, 2025
- approvalBUPRENORPHINE HYDROCHLORIDE: BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE (BUPRENORPHINE HYDROCHLORIDE) — FDA approvalDec 22, 2025
- approvalKapanol: MORPHINE SULFATE — FDA approvalDec 22, 2025
🐶 often sniffed alongside
top 8- tagApproval240 co-mentions · 120 sources
- drugGralise127 co-mentions · 127 sources
- drugNeurontin127 co-mentions · 127 sources
- tagSmall Molecule120 co-mentions · 120 sources
- companyActavis Elizabeth LLC18 co-mentions · 18 sources
- companyStrides Pharma Inc13 co-mentions · 13 sources
- tagRecall7 co-mentions · 7 sources
- companySun Pharmaceutical Industries Ltd6 co-mentions · 2 sources
comments(0)
5-min edit window · permanent after that